3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
7
Neoplasms
3
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Advanced Solid Tumors
2
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non Small Lung Cancer
1
Mesothelioma
1
KRAS p.G12C Mutant Advanced Solid Tumors
1
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Brain Neoplasms
1
Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation
1
Advanced Solid Tumor
1
Interventions
Fulvestrant
4
ribociclib
2
palbociclib
2
Irinotecan
2
Gemcitabine
2
venetoclax
1
tivozanib
1
serabelisib
1
sapanisertib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
STX-478
1
Paclitaxel
1
Metformin
1
Lomustine
1
Letrozole
1
Imlunestrant
1
Doxorubicin
1
Cetuximab
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
sotorasib
×
90 days
×
Clear all
No trials found.